Both anti-VEGF antibodies (IP, 10 μg/mouse, 2 times/week) and DAPT (po, 5 mg/kg, 3 times/week, 4 weeks) alone inhibited lung cancer growth, although to different extents (Figure 6C). The gene discussed is VEGFA; the disease is lung cancer.